Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 748
Out of 5,090 analysts
64
Total ratings
58.33%
Success rate
51.78%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $91.10 | -0.11% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $12.63 | -28.74% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $35.86 | +134.24% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $120.50 | +16.18% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $16.82 | +1.07% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $13.23 | +36.05% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $69.84 | +107.62% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $83.43 | +23.46% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $83.94 | +1.26% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $85.46 | +0.63% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $81.40 | +16.71% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $19.68 | +82.93% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.91 | +551.23% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $4.29 | +2,697.20% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.82 | +522.41% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $17.27 | -24.72% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $15.90 | +164.15% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $575.34 | -60.02% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $364.02 | -36.82% | 4 | Jul 26, 2019 |
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $91.10
Upside: -0.11%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $12.63
Upside: -28.74%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $35.86
Upside: +134.24%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $120.50
Upside: +16.18%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $16.82
Upside: +1.07%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $13.23
Upside: +36.05%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $69.84
Upside: +107.62%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $83.43
Upside: +23.46%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $83.94
Upside: +1.26%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $85.46
Upside: +0.63%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $81.40
Upside: +16.71%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $19.68
Upside: +82.93%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.91
Upside: +551.23%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $4.29
Upside: +2,697.20%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.82
Upside: +522.41%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $17.27
Upside: -24.72%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $15.90
Upside: +164.15%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $575.34
Upside: -60.02%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $364.02
Upside: -36.82%